Suárez Ferrer, C.; Arroyo Argüelles, J.; Rueda García, J.L.; García Ramírez, L.; Martin Arranz, E.; Sánchez Azofra, M.; Poza Cordón, J.; Noci Belda, J.; Martin-Arranz, M.D.
Intensification with Intravenous Ustekinumab in Refractory Crohn’s Disease. J. Clin. Med. 2024, 13, 669.
https://doi.org/10.3390/jcm13030669
AMA Style
Suárez Ferrer C, Arroyo Argüelles J, Rueda García JL, García Ramírez L, Martin Arranz E, Sánchez Azofra M, Poza Cordón J, Noci Belda J, Martin-Arranz MD.
Intensification with Intravenous Ustekinumab in Refractory Crohn’s Disease. Journal of Clinical Medicine. 2024; 13(3):669.
https://doi.org/10.3390/jcm13030669
Chicago/Turabian Style
Suárez Ferrer, Cristina, José Arroyo Argüelles, Jose Luis Rueda García, Laura García Ramírez, Eduardo Martin Arranz, María Sánchez Azofra, Joaquín Poza Cordón, Jesús Noci Belda, and Maria Dolores Martin-Arranz.
2024. "Intensification with Intravenous Ustekinumab in Refractory Crohn’s Disease" Journal of Clinical Medicine 13, no. 3: 669.
https://doi.org/10.3390/jcm13030669
APA Style
Suárez Ferrer, C., Arroyo Argüelles, J., Rueda García, J. L., García Ramírez, L., Martin Arranz, E., Sánchez Azofra, M., Poza Cordón, J., Noci Belda, J., & Martin-Arranz, M. D.
(2024). Intensification with Intravenous Ustekinumab in Refractory Crohn’s Disease. Journal of Clinical Medicine, 13(3), 669.
https://doi.org/10.3390/jcm13030669
